Abstract
The objective of this study is to examine the association of psychological distress to high-sensitivity C-reactive protein (hsCRP) levels and to examine the potential mediating role of health behaviours and pathophysiological factors. A total of 883 (393 men and 490 women) subjects, aged 36–56 years, participated in a population-based, cross-sectional study from 1997 to 1998 in Pieksämäki, Finland. Various clinical, biochemical and behavioural factors were measured, including hsCRP concentration. Psychological distress was measured using the 12-item General Health Questionnaire (GHQ-12). Subjects with low psychological distress (0 points in GHQ-12) were younger and more physically active, and their mean hsCRP level was lower when compared to subjects with medium (1–3 points) or high (4–12 points) psychological distress (1.26 ± 1.36, 1.53 ± 1.75 and 1.70 ± 1.68 mg/l, respectively, P for linearity = 0.003). Psychological distress was also associated with high relative cardiovascular risk (hsCRP >3.00 mg/l). After adjusting for gender, age, BMI, smoking, use of alcohol and leisure time physical activity, odds ratios for hsCRP >3.00 mg/l in the groups that had medium and high psychological distress were 1.32 (95% CI: 0.81–2.16) and 1.79 (95% CI: 1.05–3.04), respectively, compared with the low distress group (P for linearity 0.032). Psychological distress was associated with elevated hsCRP levels representing high relative cardiovascular risk. This association remained after adjusting for health behaviours and pathophysiological factors, supporting a direct, physiological link between psychological distress and inflammation. CRP could be an important pathophysiological mechanism through which psychological factors are associated with cardiovascular disease.
Similar content being viewed by others
References
Albert MA, Glynn RJ, Ridker PM (2003) Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107:443–447
Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM (2002) Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117–1119
Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279:48487–48490
Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249–255
Breslau N, Kilbey MM, Andreski P (1993) Nicotine dependence and major depression. New evidence from a prospective investigation. Arch Gen Psychiatry 50:31–35
Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Goncalves CA et al (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258:300–304
Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477–1482
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
Danner M, Kasl SV, Abramson JL, Vaccarino V (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347–356
Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153–160
Elovainio M, Aalto AM, Kivimaki M, Pirkola S, Sundvall J, Lonnqvist J, Reunanen A (2009) Depression and C-reactive protein: population-based health 2000 study. Psychosom Med 71:423–430
Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB et al (2005) Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 111:2299–2305
Everson-Rose SA, Lewis TT (2005) Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 26:469–500
Ford DE, Erlinger TP (2004) Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch Intern Med 164:1010–1014
Fuligni AJ, Telzer EH, Bower J, Cole SW, Kiang L, Irwin MR (2009) A preliminary study of daily interpersonal stress and C-reactive protein levels among adolescents from Latin American and European backgrounds. Psychosom Med 71:329–333
Gimeno D, Kivimaki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG et al (2009) Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39:413–423
Goldberg DP (1972) The detection of psychiatric illness by questionnaire. Maudsley monograph no. 21
Goldberg DP, Williams P (1988) A user’s guide to the general health questionnaire. NFER/Nelson, Windsor
Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27:191–197
Goodwin RD (2003) Association between physical activity and mental disorders among adults in the United States. Prev Med 36:698–703
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV (2004) Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109:3022–3028
Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA, American Heart Association, National Heart, Lung, and Blood Institute, American Diabetes Association (2004) Clinical management of metabolic syndrome: report of the American heart Association/National heart, lung, and blood Institute/American diabetes association conference on scientific issues related to management. Circulation 109:551–556
Hamer M, Stamatakis E (2008) Inflammation as an intermediate pathway in the association between psychosocial stress and obesity. Physiol Behav 94:536–539
Hamer M, Molloy GJ, Stamatakis E (2008) Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J Am Coll Cardiol 52:2156–2162
Harter MC, Conway KP, Merikangas KR (2003) Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 253:313–320
Hemingway H, Marmot M (1999) Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318:1460–1467
Holi MM, Marttunen M, Aalberg V (2003) Comparison of the GHQ-36, the GHQ-12 and the SCL-90 as psychiatric screening instruments in the Finnish population. Nord J Psychiatry 57:233–238
Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763–767
Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S (2005) Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 19:555–563
Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M (2001) Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J 141:580–585
Koenig W, Khuseyinova N, Baumert J, Meisinger C (2008) Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg cohort study, 1984–1998. Clin Chem 54:335–342
Kubzansky LD, Cole SR, Kawachi I, Vokonas P, Sparrow D (2006) Shared and unique contributions of anger, anxiety, and depression to coronary heart disease: a prospective study in the normative aging study. Ann Behav Med 31:21–29
Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Salonen JT (2005) C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J 26:1783–1789
Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W (2003) Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 17:268–275
Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143
Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006) The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60:825–830
Mattusch F, Dufaux B, Heine O, Mertens I, Rost R (2000) Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 21:21–24
McDade TW, Hawkley LC, Cacioppo JT (2006) Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med 68:376–381
McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB (2004) Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 65:634–651 (quiz 730)
Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC (1996) C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312:1061–1065
Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA (2002) Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90:1279–1283
Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, Biasucci LM et al (2004) CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation 110:e545–e549
Nabi H, Singh-Manoux A, Shipley M, Gimeno D, Marmot MG, Kivimaki M (2008) Do psychological factors affect inflammation and incident coronary heart disease: The Whitehall II study. Arterioscler Thromb Vasc Biol 28:1398–1406
Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB (2006) Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 186:113–120
Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, Qi Q, Gu W, Pang X, Liu H et al (2008) The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE 3:e1392
Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C, ATTICA Study (2004) Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people: the ATTICA study. Eur Heart J 25:492–499
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107:499–511
Petersen AM, Pedersen BK (2005) The anti-inflammatory effect of exercise. J Appl Physiol 98:1154–1162
Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31
Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H (2007) Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med 167:174–181
Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49:2129–2138
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Roy A, DeJong J, Lamparski D, George T, Linnoila M (1991) Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables. Arch Gen Psychiatry 48:428–432
Scirica BM, Morrow DA (2006) Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 113:2128–2134 (discussion 2151)
Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, Bittner V, Rutledge T, Shaw LJ, Sopko G, Bairey Merz CN et al (2007) Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the national heart, lung, and blood institute-sponsored WISE study. J Am Coll Cardiol 50:2044–2050
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135
Wener MH, Daum PR, McQuillan GM (2000) The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 27:2351–2359
Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S (2007) Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study. Biol Psychiatry 62:314–320
Wong ND, Pio J, Valencia R, Thakal G (2001) Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the national health and nutrition examination survey (NHANES) III. Prev Cardiol 4:109–114
Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978
Acknowledgments
There was no external source of funding. The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puustinen, P.J., Koponen, H., Kautiainen, H. et al. Psychological distress and C-reactive protein: do health behaviours and pathophysiological factors modify the association?. Eur Arch Psychiatry Clin Neurosci 261, 277–284 (2011). https://doi.org/10.1007/s00406-010-0134-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-010-0134-x